AratA, ÖstbergV, BurströmB, HjernA: ADHD medication in offspring of immigrants-does the income level of the country of parental origin matter?. BMC Psychiatry, 18:3, 2018.
2.
GhoshM, HolmanCDJ, PreenDB: Exploring parental country of birth differences in the use of psychostimulant medications for ADHD: A whole-population linked data study. Aust N Z J Psychiatry, 39:88–92, 2014.
3.
GhoshM, HolmanCDJ, PreenDB: Identifying cross-cultural variations in psychostimulant use for attention deficit hyperactivity disorder using linked data. Child Adolesc Psychiatry Ment Health, 11:16, 2017.
4.
JablonskaB, KosidouK, Ponce de LeonA, WettermarkB, MagnussonC, DalH, DalmanC: Neighborhood socioeconomic characteristics and utilization of ADHD medication in schoolchildren: A population multilevel study in Stockholm county. J Atten Disord, 24:265–276, 2020.
5.
KnopfH, HöllingH, HussM, SchlackR: Prevalence, determinants and spectrum of attention-deficit hyperactivity disorder (ADHD) medication of children and adolescents in Germany: Results of the German Health Interview and Examination Survey (KiGGS). BMJ Open, 2:e000477, 2012.
6.
ZuvekasSH, VitielloB: Stimulant medication use in children: A 12-year perspective. Am J, Psychiatry169:160–166, 2012.
